AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Unique biopsy needle hopes to snare market.(Medsol Corp.'s bone marrow biopsy needle)
A product recently cleared by the U.S. Food and Drug Administration (FDA) and new to the medical device community addresses market needs but also questions for its developer.
Dr. Alec Goldenberg, M.D., a hematology and medical oncology specialist, is president of Medsol Corp., New York City, a fledgling company that has recently introduced an advanced bone marrow biopsy needle.
The needle took three years of development and resulted in a pair of patents for its inventor. Dr. Goldenberg took on the project after perceiving a need for the device.
"It wasn't too hard to realize that present needles are not adequate for a number of reasons," said …
